C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/44 (2006.01) C07K 14/11 (2006.01) C12N 5/02 (2006.01) C12N 5/10 (2006.01)
Patent
CA 2111116
2111116 9303173 PCTABS00019 The present invention relates to baculovirus-expressed influenza antigens, in particular, to the influenza A membrane protein, M2, expressed from Autographa Californica nuclear polyhedrosis virus (AcNPV). The present invention further relates to a method to increase the yield of baculovirus-expressed M2 proteins in host cells by culturing the recombinant baculovirus infected host cells with an amantadine-like drug. Other aspects of the present invention relate to the use of baculovirus-expressed M2 proteins in reproducible and routine assays for the seradiagnosis of influenza A virus infections as an alternative to the more burdensome complement fixation and hemagglutination tests.
Black Renee
Kendal Alan P.
Rota Paul A.
Department Of Health And Human Services The United States Of America Represented By The Secretary
Fetherstonhaugh & Co.
LandOfFree
Improved expression of influenza a m2 protein in baculovirus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved expression of influenza a m2 protein in baculovirus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved expression of influenza a m2 protein in baculovirus... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1864625